Summary This conversation highlights the significant contributions of the Clinical and Experimental Allergy (CEA) journal to the field of allergy research and clinical practice. The hosts and Editors-in-Chief of the CEA discuss the journal's achievements, including advancements in allergy diagnosis, innovative treatments, and a focus on patient-centric research. They also outline future directions for the journal, emphasising collaboration and accessibility in allergy research. Takeaways CEA is a leading publication in allergy and immunology. The journal publishes groundbreaking research on allergy mechanisms. Innovative diagnostic methods are a focus of CEA's contributions. Promising new treatments, including biologics, are showcased. Food allergy research informs better management practices. Environmental factors influencing allergies are examined. Patient-reported outcomes are prioritized in research. The journal's Impact Factor has reached a record high. Future plans include enhancing author support and engagement. Collaboration with patient organizations is a key focus for CEA.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related